NCT03460886 is a NA clinical trial of Ipsilesional stimulation in Stroke, sponsored by Samsung Medical Center.

Who is sponsoring NCT03460886?

NCT03460886 is sponsored by Samsung Medical Center.

What drugs are being tested in NCT03460886?

Interventions in NCT03460886: Ipsilesional stimulation, Contralesional stimulation, Walking on treadmill.

What condition does NCT03460886 study?

NCT03460886 studies Stroke, Gait Disorders, Neurologic.

Is NCT03460886 still recruiting?

NCT03460886 is currently completed. Last updated 20 September 2019.

Last reviewed 2019-09-20 · How we verify

NCT03460886

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Most Effective Stimulation Site in Transcranial Direct Current Stimulation for Gait Recovery After Stoke

Completed NA Last updated 20 September 2019

What this trial tests

NA trial testing Ipsilesional stimulation in Stroke in 24 participants. Completed in 30 May 2018.

Timeline

1 February 2018

Primary endpoint
30 May 2018

30 May 2018

Quick facts

Lead sponsor	Samsung Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	24
Start date	1 February 2018
Primary completion	30 May 2018
Estimated completion	30 May 2018
Sites	1 location across South Korea

Drugs / interventions tested

Ipsilesional stimulation
Contralesional stimulation
Walking on treadmill

Conditions studied

Stroke — all drugs for Stroke →
Gait Disorders, Neurologic — all drugs for Gait Disorders, Neurologic →

Sponsor

Samsung Medical Center

Who can join

20 and older, any sex, with Stroke or Gait Disorders, Neurologic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the most effective stimulation site in transcranial direct current stimulation for gait recovery after stroke. All subjects will go through four conditions of transcranial direct current stimulation with for 30 minutes. Four conditions are 1) bihemispheric stimulation - anodal stimulation on both ipsilesional and contralesional leg area of primary motor cortex and supplementary motor area. 2) ipsilesional stimulation - anodal stimulation on ipsilesional leg area of primary motor cortex and supplementary motor area. 3) contralesional stimulation - anodal stimulation on contralesional leg area of primary motor cortex and supplementary motor area. 4) sham stimulation. Subjects will walk on treadmill for 10 minutes during transcranial direct current stimulation. Motor evoked potential and functional evaluations will be done before and after stimulation to measure the changes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke.
Elsner B, Kugler J, Pohl M, Mehrholz J. · · 2020 · cited 80× · PMID 33175411 · DOI 10.1002/14651858.cd009645.pub4

Verify or expand the search:

Other trials of Ipsilesional stimulation

Trials testing the same drug.

NCT03947645 — Intensive Neurorehabilitation and Stimulation in Chronic Stroke Patients · NA · unknown

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Samsung Medical Center trials

Trials by the same sponsor.

NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03460886 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
Last refreshed: 20 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03460886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing